What is Pinealon 20MG

Pinealon 20MG is a synthetic tripeptide bioregulator studied in research for its targeted neuroprotective effects and ability to restore cognitive function. It is intended exclusively for research use.

Regarding its chemical identity, Pinealon has a molecular formula of C18H31N7O9 and a molecular weight of 489.5 g/mol. Its reported canonical sequence is Glu-Asp-Arg. A confirmed CAS number is not available in open primary reference sources and is therefore omitted.

Its synonyms include Pinealon.

Product for research use.

Mechanism of action of Pinealon

Pinealon acts directly on the DNA of brain cells to stimulate the synthesis of specific proteins involved in learning, memory, and neuroprotection. It reduces cellular apoptosis, normalizes the metabolism of neurons, and protects against the accumulation of reactive oxygen species in the brain.

Pharmacokinetics and pharmacodynamics of Pinealon

Pinealon has an extremely short half-life in biological media. It rapidly crosses the blood-brain barrier, enters the nuclei of neurons, and exerts a long-lasting epigenetic regulatory effect before being quickly broken down.

Scientific evidence on Pinealon

The available evidence on Pinealon is preliminary and largely inconclusive, and should be interpreted with caution. The literature describes it as having been investigated for multiple indications in preclinical models.

Studied in preclinical models of traumatic brain injury, ischemic stroke, Alzheimer’s disease, and general age-related cognitive decline. Evidence indicates it accelerates the restoration of maze navigation and spatial memory in damaged animal models.

Pinealon applications in research

Ideal for (research context):
– In vitro and preclinical studies of its specific receptor pathways.
– Investigation of tissue repair, cell proliferation, and functional restoration in laboratory models.
– Comparative work with related peptides.

Not applicable for:
– clinical, diagnostic or therapeutic use.
– Any administration to humans or animals outside of an authorized research protocol.

Product for research use.

Pinealon protocols in preclinical studies

The literature consulted does not include numerical doses from studies that can be cited for Pinealon, so no trial schemes or quantities are specified.

The presentations of this product (20MG) refer only to the amount of lyophilized peptide per vial (or volume for liquids) and do not constitute a dosage recommendation. The design of any protocol, including concentrations and working volumes, is the responsibility of the researcher, based on their experimental objectives and the relevant primary literature.

Information provided exclusively for research purposes.

Reconstitution and manipulation of Pinealon

As a general guideline for laboratory handling, lyophilized peptides such as Pinealon are usually reconstituted with bacteriostatic water (sterile water with approximately 0.9% benzyl alcohol).

Add the solvent slowly down the side of the vial, letting it run over the lyophilized powder; avoid injecting the stream directly onto the powder.
Do not shake: gently rotate the vial until completely dissolved.
Adjust the solvent volume according to the desired working concentration, considering the 20MG contents of the vial.

These guidelines are for general technique and do not replace the internal procedures of each laboratory.

Pinealon Stability and Storage

As a standard laboratory handling procedure for peptides:

Freeze-dried (unreconstituted): This is the most stable form. It is best preserved by freezing and protecting it from moisture and light for long-term storage.
Reconstituted: once in solution, the peptide is less stable and must be kept refrigerated, being used within a short period; for extended storage, freezing in aliquots is usually preferred.
Avoid repeated freeze-thaw cycles, as they can degrade the peptide.

Given that the molecule is characterized by rapid enzymatic degradation in biological media, careful cold chain management is especially relevant.

Documented Pinealon security profile

The documented safety information in open sources for Pinealon is limited and should be interpreted with caution, also considering that it is research material and not for clinical use.

Targeting the central nervous system presents theoretical risks of overstimulation. However, the literature primarily describes Pinealon as a homeostatic regulator rather than a stimulant, with an excellent theoretical safety profile regarding neurotoxicity.

Formal contraindications and adverse event rates are not available in the consulted literature, so no figures are reported.

Pinealon in a comparative context

Pinealon is the synthetic counterpart to the natural brain extract Cerluten. Compared to Semax (a powerful cognitive stimulant), Pinealon is a foundational repair peptide that aims to restore baseline neurological health rather than acutely spike neurotransmitter levels.

History and development of Pinealon

Developed by Vladimir Khavinson. It was synthesized based on the amino acid sequence isolated from the cerebral cortex of young animals, specifically designed to combat central nervous system aging and neurodegeneration.